MAPK3 and endometrial cancer: Moreover, phospho-antibody microarrays revealed that the MAPK-ERK1/2 signaling pathway is involved in AMF-mediated endometrial cancer and that the re-activation of MAPK-ERK1/2 signaling with exogenous PGI in co-cultured EC cells induced migration, invasion and proliferation.